Evaluation of the Evolution of Patient Care Within the Spinal Pathology Department (SPINDATA)
29 maj 2026 uppdaterad av: University Hospital, Bordeaux
Evaluation of the Evolution of the Quality of Life of Patients Treated by the Spinal Pathology Department
Spinal conditions are a major public health issue.
Their management by surgical treatment is constantly improving and surgical procedures or implantable medical devices are experiencing significant progress.
These innovations have not yet all been precisely evaluated but have already led to significant changes in care practices.
The primary objective of our study is to describe, via an exhaustive collection of data, the quarterly evolution over 5 years of practices in the management of spinal pathologies.
Studieöversikt
Status
Rekrytering
Intervention / Behandling
Detaljerad beskrivning
The team will conduct a monocentric (department of spine surgery, University Hospital of Bordeaux, France) prospective observational study during 5 years, involving all patients treated for a spinal condition (including degenerative pathology of the lumbar, thoracic or cervical spine, deformities of the spine and for the traumatic, infectious and tumor pathologies).The data collected will concern the general condition of the patients, their reasons for consultation, the details of their spinal pathology and its impact using specific functional assessment self-questionnaires, as well as the care provided.
A three years follow-up will be planned
Studietyp
Interventionell
Inskrivning (Beräknad)
15000
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studiekontakt
- Namn: Benjamin BOUYER, PROF
- Telefonnummer: +335 56 79 87 18
- E-post: b.bouyer@chu-bordeaux.fr
Studera Kontakt Backup
- Namn: Ouidad BEN KACEM
- Telefonnummer: 14 367 +335 56 79 87 18
- E-post: ouidad.hasnaoui@chu-bordeaux.fr
Studieorter
-
-
-
Bordeaux, Frankrike, 33000
- Rekrytering
- Hôpital Pellegrin, Centre Hospitalier Universitaire de Bordeaux
-
Kontakt:
- Ouidad BEN KACEM
- Telefonnummer: 14 367 +335 56 79 87 18
- E-post: ouidad.hasnaoui@chu-bordeaux.fr
-
Kontakt:
- Benjamin BOUYER, MD
- Telefonnummer: +335 56 79 87 18
- E-post: b.bouyer@chu-bordeaux.fr
-
Huvudutredare:
- Benjamin BOUYER, MD
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion criteria:
- Patient > 18 years old
- Minor patient, able to accept the data collection, with the consent of the holder(s)
- Patient consulting for a medical reason involving a spinal pathology in the investigating center (spinal surgery department): Degenerative pathology of the thoracic or lumbar spine; Degenerative pathology of the cervical spine; Deformation of the spine; Urgent traumatic, infectious and tumor pathologies.
Exclusion criteria:
- Patient under guardianship or curators,
- Persons deprived of liberty by judicial or administrative decision,
- Persons undergoing psychiatric treatment under duress requiring the consent of the legal representative
- Persons unable to express their consent,
- Persons under legal protection,
- Patient not affiliated to a social protection scheme.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Patient consulting in spine surgery
quality of life scales for all patient consulting in spine surgery unit and psychological rating scales only for patients who require it (determined by the surgeon)
|
quality of life scales for all patient consulting in spine surgery unit and psychological rating scales only for patients who require it (determined by the surgeon)
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Recourse to surgery
Tidsram: Inclusion visit
|
Rate of recourse to surgery by type of spinal pathology given (cervical, thoracic or lumbar degenerative or spinal deformity).
|
Inclusion visit
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Clinical characteristics
Tidsram: Inclusion visit, Visit Month 24 and Visit Month 36
|
Weight of patient
|
Inclusion visit, Visit Month 24 and Visit Month 36
|
|
Socio-demographic
Tidsram: Inclusion visit, Visit Month 24 and Visit Month 36
|
Socio-demographic characteristics (occupation)
|
Inclusion visit, Visit Month 24 and Visit Month 36
|
|
Socio-demographic
Tidsram: Inclusion visit, Visit Month 24 and Visit Month 36
|
Socio-demographic characteristics (sports activities)
|
Inclusion visit, Visit Month 24 and Visit Month 36
|
|
Questionnaire of Quality of life
Tidsram: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
Health-related quality of life evaluated using the SF-36 questionnaire.
This questionnaire is composed of 11 items and total score from 0 to 100
|
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
|
Questionnaire of Quality of life
Tidsram: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
Health-related quality of life evaluated using the EQ-5D-5L questionnaire.
This questionnaire is composed of 5 items and total score from 5 to 25
|
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
|
Lower back pain.
Tidsram: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
The ODI (Oswestry Disability Index) score is used to measure the degree of disability related to lower back pain. The questionnaire contains 10 items, each scored from 0 to 5 points. The maximum total score is 50 points. |
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
|
Cervical pain
Tidsram: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
The NDI is used to measure disability related to cervical pain via a standardized questionnaire. The questionnaire contains 10 items, each scored from 0 to 5 points. The maximum total score is 50 points. The higher the percentage, the greater the functional impairment. |
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
|
Cervical function, Upper limb function, Lower limb function, Bladder function, Quality of life.
Tidsram: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
The JOACMEQ (Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire) provides 5 independent scores (0-100): Cervical function, Upper limb function, Lower limb function, Bladder function, Quality of life. Each area gives a score between 0 (worst) and 100 (best condition). |
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
|
Evaluation of the safety of care provided.
Tidsram: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
For each type of spinal pathology, measurement of: - Incidence of serious medical complications |
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
|
Clinical characteristics
Tidsram: Inclusion visit, Visit Month 24 and Visit Month 36
|
Body Mass Index of patient
|
Inclusion visit, Visit Month 24 and Visit Month 36
|
|
Evaluation of the safety of care provided.
Tidsram: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
For each type of spinal pathology, measurement of Incidence of mortality, assessed by recalling patients lost to follow-up
|
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
|
Evaluation of the safety of care provided.
Tidsram: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
For each type of spinal pathology, measurement of Incidence of surgical site infections
|
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
|
Evaluation of the safety of care provided.
Tidsram: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
For each type of spinal pathology, measurement of Incidence of mechanical complications
|
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
|
Evaluation of the safety of care provided.
Tidsram: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
For each type of spinal pathology, measurement of Incidence of neurological complications
|
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
|
Evaluation of the safety of care provided.
Tidsram: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
For each type of spinal pathology, measurement of Incidence of surgical re-interventions
|
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Utredare
- Huvudutredare: Benjamin BOUYER, PROF, University Hospital, Bordeaux
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
25 maj 2023
Primärt slutförande (Beräknad)
1 augusti 2028
Avslutad studie (Beräknad)
1 augusti 2031
Studieregistreringsdatum
Först inskickad
5 mars 2026
Först inskickad som uppfyllde QC-kriterierna
29 maj 2026
Första postat (Faktisk)
4 juni 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
4 juni 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
29 maj 2026
Senast verifierad
1 maj 2026
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- CHUBX 2022/58
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .